Arthritis Res Ther. 2008;10(3):111. Epub 2008 Jun 2.

High mobility group box-1 protein as a tumor necrosis factor-independent therapeutic target in rheumatoid arthritis.

Abstract

Rheumatoid arthritis (RA) remains a prevalent disease worldwide that causes significant morbidity and mortality despite recent therapeutics. High mobility group box-1 (HMGB1) protein, originally appreciated as an intranuclear DNA binding protein, has been implicated as an integral mediator in the pathogenesis of animal arthritides and RA disease in humans. Our current understanding of HMGB1 has promoted the development of targeting therapies that have improved outcomes in animal models of inflammation. In the previous issue of Arthritis Research & Therapy, Sundberg and colleagues address, for the first time in a prospective cohort study, whether HMGB1 expression is dependent upon tumor necrosis factor activity in patients with RA.

Comment on

Arthritis Res Ther. 2008;10(2):R33.

PMID:: 18557992; [PubMed - indexed for MEDLINE]
PMCID:: PMC2483447

Free PMC Article

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Systemic TNF blockade does not modulate synovial expression of the pro-inflammatory mediator HMGB1 in rheumatoid arthritis patients--a prospective clinical study. [Arthritis Res Ther. 2008]
Systemic TNF blockade does not modulate synovial expression of the pro-inflammatory mediator HMGB1 in rheumatoid arthritis patients--a prospective clinical study.
Sundberg E, Grundtman C, Af Klint E, Lindberg J, Ernestam S, Ulfgren AK, Harris HE, Andersson U. Arthritis Res Ther. 2008; 10(2):R33. Epub 2008 Mar 17.
Review HMGB1 as a mediator of necrosis-induced inflammation and a therapeutic target in arthritis. [Rheum Dis Clin North Am. 2004]
Review HMGB1 as a mediator of necrosis-induced inflammation and a therapeutic target in arthritis.
Andersson U, Tracey KJ. Rheum Dis Clin North Am. 2004 Aug; 30(3):627-37, xi.
Review Bench to bedside: HMGB1-a novel proinflammatory cytokine and potential therapeutic target for septic patients in the emergency department. [Acad Emerg Med. 2004]
Review Bench to bedside: HMGB1-a novel proinflammatory cytokine and potential therapeutic target for septic patients in the emergency department.
Sama AE, D'Amore J, Ward MF, Chen G, Wang H. Acad Emerg Med. 2004 Aug; 11(8):867-73.
High mobility group box-1 as a therapeutic target downstream of tumor necrosis factor. [J Infect Dis. 2003]
High mobility group box-1 as a therapeutic target downstream of tumor necrosis factor.
Czura CJ, Yang H, Tracey KJ. J Infect Dis. 2003 Jun 15; 187 Suppl 2:S391-6.
[Expression of high mobility group box chromosomal protein 1 in peripheral blood of patients with rheumatoid arthritis]. [Zhonghua Nei Ke Za Zhi. 2007]
[Expression of high mobility group box chromosomal protein 1 in peripheral blood of patients with rheumatoid arthritis].
Zuo XX, Zhou YO, Gong YH, Wang YP, Tang DL, Xiao XZ. Zhonghua Nei Ke Za Zhi. 2007 Jul; 46(7):547-50.

See reviews... See all...

Cited by 1 PubMed Central article

Amino acid residues 201-205 in C-terminal acidic tail region plays a crucial role in antibacterial activity of HMGB1. [J Biomed Sci. 2009]
Amino acid residues 201-205 in C-terminal acidic tail region plays a crucial role in antibacterial activity of HMGB1.
Gong W, Li Y, Chao F, Huang G, He F. J Biomed Sci. 2009 Sep 14; 16:83. Epub 2009 Sep 14.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

High mobility group box-1 protein as a tumor necrosis factor-independent therape...
High mobility group box-1 protein as a tumor necrosis factor-independent therapeutic target in rheumatoid arthritis.
Arthritis Res Ther. 2008 ;10(3):111. Epub 2008 Jun 2 .

PubMed
Effect of gender and highly active antiretroviral therapy on HIV-related pulmona...
Effect of gender and highly active antiretroviral therapy on HIV-related pulmonary arterial hypertension: results of the HIV-HEART Study.
HIV Med. 2008 Aug ;9(7):550-6. Epub 2008 Jun 28 .

PubMed
Bruxism physiology and pathology: an overview for clinicians.
Bruxism physiology and pathology: an overview for clinicians.
J Oral Rehabil. 2008 Jul ;35(7):476-94.

PubMed
HIV testing and counselling policies and practices in Europe: lessons learned, w...
HIV testing and counselling policies and practices in Europe: lessons learned, ways forward.
HIV Med. 2008 Jul ;9 Suppl 2:30-3.

PubMed
Optimal HIV testing and earlier care: the way forward in Europe.
Optimal HIV testing and earlier care: the way forward in Europe.
HIV Med. 2008 Jul ;9 Suppl 2:1-5.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: